IRIS

Terbacil

CASRN 5902-51-2

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (8 pp, 90 K) last updated: 01/31/1987

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Endocrine, Hepatic 1.3 x 10-2 Increase in thyroid/body weight ratio; slight increase in liver weights; elevated alkaline phosphatase NOEL : 1.25
mg/kg-day
100 Medium

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (8 pp, 90 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (8 pp, 90 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (8 pp, 90 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (8 pp, 90 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.